
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | $167.5M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | $88.2M | $73.9M | $83.5M | |
Selling, General & Admin | -- | -- | $22.8M | $24.6M | $26.4M | |
Other Inc / (Exp) | -- | -- | -$5.9M | -$3.8M | -$8.8M | |
Operating Expenses | -- | -- | $111M | $98.6M | $109.9M | |
Operating Income | -- | -- | -$111M | -$98.6M | $57.6M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -$114.9M | -$100.4M | $53.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | $1.2M | |
Net Income to Company | -- | -- | -$114.9M | -$100.4M | $52.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -$114.9M | -$100.4M | $52.2M | |
Basic EPS (Cont. Ops) | -- | -- | -$3.29 | -$2.87 | $0.08 | |
Diluted EPS (Cont. Ops) | -- | -- | -$3.29 | -$2.87 | $0.08 | |
Weighted Average Basic Share | -- | -- | $35M | $35M | $43.8M | |
Weighted Average Diluted Share | -- | -- | $35.4M | $35.4M | $43.8M | |
EBITDA | -- | -- | -$107.2M | -$94.5M | $60.9M | |
EBIT | -- | -- | -$111M | -$98.6M | $57.6M | |
Revenue (Reported) | -- | -- | -- | -- | $167.5M | |
Operating Income (Reported) | -- | -- | -$111M | -$98.6M | $57.6M | |
Operating Income (Adjusted) | -- | -- | -$111M | -$98.6M | $57.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $21.9M | $27.6M | |
Selling, General & Admin | -- | -- | -- | $6.1M | $7.8M | |
Other Inc / (Exp) | -- | -- | -- | -$4.8M | -- | |
Operating Expenses | -- | -- | -- | $28M | $35.4M | |
Operating Income | -- | -- | -- | -$28M | -$35.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$32.5M | -$32.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$32.5M | -$32.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$32.5M | -$32.8M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.93 | -$1.15 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.93 | -$1.15 | |
Weighted Average Basic Share | -- | -- | -- | $35M | $28.6M | |
Weighted Average Diluted Share | -- | -- | -- | $35.4M | $28.6M | |
EBITDA | -- | -- | -- | -$27.1M | -$34.7M | |
EBIT | -- | -- | -- | -$28M | -$35.4M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$28M | -$35.4M | |
Operating Income (Adjusted) | -- | -- | -- | -$28M | -$35.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | $89.2M | |
Selling, General & Admin | -- | -- | -- | -- | $28.1M | |
Other Inc / (Exp) | -- | -- | -- | -$4.8M | -$4.1M | |
Operating Expenses | -- | -- | -- | -- | $117.3M | |
Operating Income | -- | -- | -- | -- | $50.2M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -- | $53.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -- | $51.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -- | $51.9M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$1.24 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$1.24 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -- | -- | $53.2M | |
EBIT | -- | -- | -- | -- | $50.2M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -- | $50.2M | |
Operating Income (Adjusted) | -- | -- | -- | -- | $50.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | -- | -- | -- | |
Gross Profit | -- | -- | -- | -- | -- | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | $21.9M | $27.6M | |
Selling, General & Admin | -- | -- | -- | $6.1M | $7.8M | |
Other Inc / (Exp) | -- | -- | -- | -$4.8M | -- | |
Operating Expenses | -- | -- | -- | $28M | $35.4M | |
Operating Income | -- | -- | -- | -$28M | -$35.4M | |
Net Interest Expenses | -- | -- | -- | -- | -- | |
EBT. Incl. Unusual Items | -- | -- | -- | -$32.5M | -$32.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | -- | -- | |
Net Income to Company | -- | -- | -- | -$32.5M | -$32.8M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -- | -- | -- | -$32.5M | -$32.8M | |
Basic EPS (Cont. Ops) | -- | -- | -- | -$0.93 | -$1.15 | |
Diluted EPS (Cont. Ops) | -- | -- | -- | -$0.93 | -$1.15 | |
Weighted Average Basic Share | -- | -- | -- | $35M | $28.6M | |
Weighted Average Diluted Share | -- | -- | -- | $35.4M | $28.6M | |
EBITDA | -- | -- | -- | -$27.1M | -$34.7M | |
EBIT | -- | -- | -- | -$28M | -$35.4M | |
Revenue (Reported) | -- | -- | -- | -- | -- | |
Operating Income (Reported) | -- | -- | -- | -$28M | -$35.4M | |
Operating Income (Adjusted) | -- | -- | -- | -$28M | -$35.4M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $99.9M | $29.2M | $196.8M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | $6.2M | $5M | $4.9M | |
Total Current Assets | -- | -- | $106.1M | $34.1M | $201.7M | |
Property Plant And Equipment | -- | -- | $41.2M | $35M | $29.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $2.6M | $2.4M | $9M | |
Total Assets | -- | -- | $150M | $71.5M | $240.5M | |
Accounts Payable | -- | -- | $1.6M | $2M | $1.9M | |
Accrued Expenses | -- | -- | $7.5M | $2.9M | $6M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | $4.3M | $4.5M | $4.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $20.8M | $16.3M | $20.7M | |
Long-Term Debt | -- | -- | -- | $20.1M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $432.4M | $445.4M | $551.7M | |
Common Stock | -- | -- | $2K | $2K | $2K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -$282.5M | -$373.8M | -$311.2M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -$282.5M | -$373.8M | -$311.2M | |
Total Liabilities and Equity | -- | -- | $150M | $71.5M | $240.5M | |
Cash and Short Terms | -- | -- | $99.9M | $29.2M | $196.8M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | -- | -- | $294.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | $5.3M | |
Total Current Assets | -- | -- | -- | -- | $299.7M | |
Property Plant And Equipment | -- | -- | -- | -- | $28.8M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | -- | -- | $4.3M | |
Total Assets | -- | -- | -- | -- | $332.8M | |
Accounts Payable | -- | -- | -- | -- | $2.4M | |
Accrued Expenses | -- | -- | -- | -- | $7.3M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $4.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | -- | -- | $18.6M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | -- | -- | $40.8M | |
Common Stock | -- | -- | -- | -- | $44K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | -- | -- | -- | -- | $292.1M | |
Total Liabilities and Equity | -- | -- | -- | -- | $332.8M | |
Cash and Short Terms | -- | -- | -- | -- | $294.4M | |
Total Debt | -- | -- | -- | -- | -- |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$114.9M | -$100.4M | $52.2M | |
Depreciation & Amoritzation | -- | -- | $3.8M | $4.1M | $3.3M | |
Stock-Based Compensation | -- | -- | $6.7M | $8.7M | $9.6M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$99.2M | -$86.8M | $76M | |
Capital Expenditures | -- | -- | -- | -- | $1.1M | |
Cash Acquisitions | -- | -- | -$1.2M | -- | -- | |
Cash From Investing | -- | -- | -$3.2M | -$441K | -$1.1M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $16.2M | $24.5M | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$3.2M | |
Cash From Financing | -- | -- | $1.7M | $16.4M | $92.8M | |
Beginning Cash (CF) | -- | -- | $201.8M | $101.1M | $30.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -$100.6M | -$70.9M | $167.7M | |
Ending Cash (CF) | -- | -- | $101.1M | $30.2M | $197.9M | |
Levered Free Cash Flow | -- | -- | -$101.2M | -$87.3M | $74.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$32.5M | -$32.8M | |
Depreciation & Amoritzation | -- | -- | -- | $950K | $684K | |
Stock-Based Compensation | -- | -- | -- | $2.3M | $3.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$23.4M | -$29.5M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$279K | -$299K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $24.2M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$500K | |
Cash From Financing | -- | -- | -- | $24.6M | $127.4M | |
Beginning Cash (CF) | -- | -- | -- | $30.2M | $197.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $865K | $97.6M | |
Ending Cash (CF) | -- | -- | -- | $31.1M | $295.5M | |
Levered Free Cash Flow | -- | -- | -- | -$23.7M | -$29.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -- | $51.9M | |
Depreciation & Amoritzation | -- | -- | -- | -- | $3M | |
Stock-Based Compensation | -- | -- | -- | $2.3M | $10.6M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -- | $69.9M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -- | -$1.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | $259K | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$3.7M | |
Cash From Financing | -- | -- | -- | -- | $195.6M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | -- | $264.4M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -- | -- | $68.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -- | -$32.5M | -$32.8M | |
Depreciation & Amoritzation | -- | -- | -- | $950K | $684K | |
Stock-Based Compensation | -- | -- | -- | $2.3M | $3.2M | |
Change in Accounts Receivable | -- | -- | -- | -- | -- | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -- | -$23.4M | -$29.5M | |
Capital Expenditures | -- | -- | -- | -- | -- | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | -- | -$279K | -$299K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | $24.2M | -- | |
Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -- | -- | -$500K | |
Cash From Financing | -- | -- | -- | $24.6M | $127.4M | |
Beginning Cash (CF) | -- | -- | -- | $30.2M | $197.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | -- | $865K | $97.6M | |
Ending Cash (CF) | -- | -- | -- | $31.1M | $295.5M | |
Levered Free Cash Flow | -- | -- | -- | -$23.7M | -$29.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.